Domov › Rak dojke › Colorado › Aurora
Klinične študije za Rak dojke v Aurora, CO
28 študij za Rak dojke išče udeležence na lokacijah v Aurora in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Phase 1 Study of OP-3136 in Advanced or Metastatic Solid Tumors
Vključevanje udeležencevFaza 1
- University of Colorado, Aurora
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
- Rocky Mountain Regional VA Medical Center, Aurora
- UCHealth University of Colorado Hospital, Aurora
A Study of Patritumab Deruxtecan (HER3-DXd) in Combination With Trastuzumab Deruxtecan (T-DXd) in Participants With HR-Positive, HER2-Low or HER2-Ultralow Unresectable or Metastatic Breast Cancer
Vključevanje udeležencevFaza 1/2
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
Vključevanje udeležencevFaza 2
- University of Colorado School of Medicine, Aurora
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
Vključevanje udeležencevFaza 3
- University of Colorado Anschutz Medical Campus ( Site 0061), Aurora
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Vključevanje udeležencevFaza 3
- Research Site, Aurora
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
Vključevanje udeležencevFaza 3
- University of Colorado Anschutz Medical Campus, Aurora
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Vključevanje udeležencevFaza 3
- Clinical Trial Site, Aurora
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Vključevanje udeležencevFaza 1
- University of Colorado Cancer Center, Aurora
Study of Psilocybin Assisted Psychotherapy to Address Fear of Recurrence
Vključevanje udeležencevFaza 1
- Outpatient CTRC, Aurora
- University of Colorado Cancer Center, Aurora
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Vključevanje udeležencevFaza 3
- UCHealth University of Colorado Hospital, Aurora
A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases
Vključevanje udeležencevFaza 2
- University Of Colorado Hospital - Anschutz Cancer Pavilion, Aurora
A Study of Izalontamab Brengitecan Versus Chemotherapy in Participants With Previously Untreated, Locally Advanced, Recurrent Inoperable, or Metastatic Triple-negative Breast Cancer Ineligible for Anti-PD(L)1 Drugs (IZABRIGHT-Breast01)
Vključevanje udeležencevFaza 2/3
- Local Institution - 0289, Aurora
E-Mindfulness Approaches for Living After Breast Cancer
Vključevanje udeležencevFaza 3
- UCHealth University of Colorado Hospital, Aurora
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- University of Colorado Cancer Center, Aurora
Study of Patritumab Deruxtecan With Other Anticancer Agents in Participants With HER2 Positive Breast Cancer That Has Spread and Cannot Be Surgically Removed (MK-1022-009)
Vključevanje udeležencevFaza 1/2
- University of Colorado Anschutz Medical Campus ( Site 0057), Aurora
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Vključevanje udeležencevFaza 2
- University of Colorado Cancer Center, Aurora
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Vključevanje udeležencevFaza 3
- Rocky Mountain Cancer Centers LLP, Aurora
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Vključevanje udeležencevFaza 3
- UCHealth University of Colorado Hospital, Aurora
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Vključevanje udeležencevOpazovalna študija
- Rocky Mountain Cancer Centers-Aurora, Aurora
Improving Care for Rural Patients With Solid Tumors
Vključevanje udeležencev
- University of Colorado Hospital, Aurora
Telehealth Exercise Program Evaluating Fatigue and Physical Function in Rural Cancer Survivors
Vključevanje udeležencevFaza 2
- University of Colorado Anschutz Medical Campus, Aurora
The Immune System's Response to Young Women's Breast Cancer
Vključevanje udeležencevOpazovalna študija
- University of Colorado Denver, Aurora
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Vključevanje udeležencevOpazovalna študija
- UCHealth Cancer Care - Anschutz Medical Campus - University of Colorado Cancer Center, Aurora
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Vključevanje udeležencevOpazovalna študija
- Massive Bio SYNERGY-AI site, Aurora
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Vključevanje udeležencevOpazovalna študija
- Rocky Mountain Cancer Centers, Aurora
- University of Colorado Cancer Center, Aurora
CtDNA Based MRD Testing for NAC Monitoring in TNBC
Vključevanje udeležencevOpazovalna študija
- University of Colorado Cancer Center, Aurora
Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy
Vključevanje udeležencevFaza 3
- Rocky Mountain Cancer Centers - Aurora, Aurora
Študije za Rak dojke v drugih mestih
- New York City, NY136 študij
- Houston, TX126 študij
- Boston, MA112 študij
- Nashville, TN81 študij
- Los Angeles, CA73 študij
- Edison, NJ68 študij
- St. Louis, MO64 študij
- Queens, NY64 študij
- Durham, NC64 študij
- Chicago, IL59 študij
- Philadelphia, PA56 študij
- Dallas, TX55 študij
Druge študije v Aurora
- Rak (vse vrste)35 študij
- Kolorektalni rak32 študij
- Nemalicelični pljučni rak31 študij
- Rak jajčnikov25 študij
- Metastatski rak25 študij
- Sladkorna bolezen tipa 123 študij
- Debelost22 študij
- Rak prostate19 študij
- Rak pljuč19 študij
- Srčno popuščanje18 študij
- Melanom18 študij
- Akutna mieločna levkemija16 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.